Metformin: a cheap and well‐tolerated drug that provides benefits for viral infections
Open Access
- 21 November 2012
- journal article
- research article
- Published by Wiley in HIV Medicine
- Vol. 14 (4) , 233-240
Abstract
Objectives Insulin resistance in viral infections is common. We have explored the effectiveness of metformin for alleviating insulin resistance in HIV‐infected patients and assessed the relevance of the ataxia‐telangiectasia mutated (ATM) rs11212617 variant in the clinical response with the rationale that metformin modulates cellular bioenergetics in an ATM‐dependent process. Methods HIV‐infected patients (n = 385) were compared with controls recruited from the general population (n = 300) with respect to the genotype distribution of the ATM rs11212617 variant and its influence on selected metabolic and inflammatory variables. We also followed up a subset of male patients with HIV and hepatitis C virus (HCV) coinfection (n = 47) who were not receiving antiviral treatment and for whom metformin was prescribed for insulin resistance, which tends to have a higher incidence and severity in coinfected patients. Results Among the HIV‐infected patients, human cytomegalovirus (91.9%) and HCV (62.3%) coinfections were frequent. Selected metabolic and/or inflammatory variables were significantly altered in infected patients. Treatment with metformin in HIV and HCV coinfected patients was well tolerated and significantly increased the sensitivity of peripheral tissues to insulin. The minor allele (C) of the rs11212617 variant was associated with treatment success and may affect the course of insulin resistance in response to metformin (odds ratio 1.21; 95% confidence interval 1.07–1.39; P = 0.005). There were no differences between treated and untreated patients in viral loads or variables measuring immune defence, indicating that toxicity is unlikely. Conclusions We provide novel data suggesting that identification of the ATM rs11212617 variant may be important in assessing the glycaemic response to metformin treatment for insulin resistance in HIV‐infected patients.Keywords
This publication has 33 references indexed in Scilit:
- A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohortsDiabetologia, 2012
- Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndromeAIDS, 2012
- Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infectionProceedings of the National Academy of Sciences, 2012
- Alternative Macrophage Activation and MetabolismAnnual Review of Pathology: Mechanisms of Disease, 2011
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetesNature Genetics, 2010
- ATM activates the pentose phosphate pathway promoting anti‐oxidant defence and DNA repairThe EMBO Journal, 2010
- Infection with HIV and HCV enhances the release of fatty acid synthase into circulation: evidence for a novel indicator of viral infectionBMC Gastroenterology, 2010
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJournal of Clinical Investigation, 2010
- Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinaseProceedings of the National Academy of Sciences, 2010
- Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin actionJournal of Clinical Investigation, 2007